NANOBIOTIX and PharmaEngine Mutually Agree to Conclude Collaboration

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with ...

Full "IntellAsia: Resources" article